Skip to content
NBDC Human Database

No datasets in the cart.

Due to system maintenance, the application system, application review by the Data Access Committee will be unavailable during the following period.
Schedule: October 5th (Mon), 2026, 9:00 - October 7th (Wed), 2026, 15:00 (JST)
We apologize for any inconvenience this may cause and appreciate your understanding.

We are currently receiving a large number of applications for data submission, and the review process is taking longer than usual.We sincerely apologize for the delay and kindly ask for your understanding. When submitting an application, we would greatly appreciate it if you could allow sufficient time for the processing.

Following a change to our organizational structure effective April 1, 2026, this division has been renamed from the "Database Center for Life Science, Joint Support-Center for Data Science Research" to the "Database Division for Life Science (DBCLS), BioData Science Initiative (BSI), National Institute of Genetics (NIG)". Where the former name still appears in the guidelines, please read it as the new name.

Dataset ID

JGAD000226

Type of data
NGS (Exome, Target Capture, RNA-seq)
Access criteria
Controlled-access (Type I)
Total data volume
186 GB
File formats
  • FASTQ
  • BAM
Research
hum0130
Date published
2020-09-28
Date modified
2024-06-17

Analysis method

WES

Materials and participants
POEMS syndrome (ICD10: C90.2): 15 cases
  • Health status
    Affected
  • Subject count
    15 (Individual)
Disease
POEMS syndrome (C902)
Sample description
DNA purified from Plasma cells or buccal cell of POEMS syndrome, MM, MGUS
  • Tissue
    Bone marrow, Buccal mucosa, Plasma cell
  • Tumor / normal
    Mixed
Sample provider
N/A
Experimental method
WES
Target
Coding exons
Reagent kit
SureSelect Human All Exon V5
Fragmentation
Ultrasonic fragmentation
Platform
Illumina HiSeq 2500
Read type
Paired-end
Read length
121 bp
Reference genome
GRCh37

Targeted DNA sequencing

Materials and participants
POEMS syndrome (ICD10: C90.2): 20 cases
  • Health status
    Affected
  • Subject count
    20 (Individual)
Disease
POEMS syndrome (C902)
Sample description
DNA purified from Plasma cells or buccal cell of POEMS syndrome, MM, MGUS
  • Tissue
    Bone marrow, Buccal mucosa, Plasma cell
  • Tumor / normal
    Mixed
Sample provider
N/A
Experimental method
Targeted DNA sequencing
Target
Coding exons
Reagent kit
SureSelect Custom
Fragmentation
Ultrasonic fragmentation
Platform
Illumina MiSeq
Read type
Paired-end
Read length
273 bp
Reference genome
GRCh37

RNA-seq

Materials and participants
POEMS syndrome (ICD10: C90.2): 5 cases
MM (ICD10: C90.0): 4 cases
MGUS (ICD10: D47.2): 5 cases
Normal control (lymphoma without BM invasion): 3 cases
  • Health status
    Affected
  • Subject count
    17 (Individual)
Disease
POEMS syndrome (C902)
MM (C900)
MGUS (D472)
Sample description
RNA purified from Plasma cells or buccal cell of POEMS syndrome, MM, MGUS and normal controls
  • Tissue
    Bone marrow, Plasma cell
  • Tumor / normal
    Tumor
Sample provider
N/A
Experimental method
RNA-seq
Target
N/A
Reagent kit
NEBNext Ultra DNA Library Prep Kit for Illumina
SMART-Seq v4 Ultra Low Input RNA Kit
Fragmentation
Ultrasonic fragmentation
Platform
Illumina HiSeq 1500
Read type
Single-end
Read length
60 bp